This inventor holds 1 USPTO granted patent. Top assignee: Guangzhou Cellprotek Pharmaceutical Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Yana Wang: Innovator in Pulmonary Disease Treatment
Introduction
Yana Wang is a prominent inventor based in Guangdong, China. She has made significant contributions to the field of medicine, particularly in the treatment of pulmonary diseases. Her innovative work focuses on the use of small molecule compounds to address lung epithelial cell injury and vascular endothelial cell injury.
Latest Patents
Yana Wang holds a patent for the "Use of small molecule compounds in the treatment of diseases mediated by lung epithelial cell injury and/or vascular endothelial cell injury." This patent discloses the use of 5α-androst-3β,5,6β-triol or its analogues, deuterated compounds, or pharmaceutically acceptable salts in the manufacture of a medicament for treating pulmonary diseases. The compounds she has developed can significantly inhibit the up-regulation of PFKFB3 expression, reduce lactate accumulation, and mitigate both vascular endothelial and alveolar epithelial cell injuries. This innovative approach can effectively treat diseases associated with lung epithelial cell injury.
Career Highlights
Yana Wang is currently associated with Guangzhou Cellprotek Pharmaceutical Ltd., where she continues her research and development efforts. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from pulmonary conditions.
Collaborations
Yana collaborates with notable colleagues, including Bingzheng Lu and Yupin Chen, who contribute to her research initiatives and help advance her innovative projects.
Conclusion
Yana Wang's contributions to the field of pulmonary disease treatment through her innovative patent demonstrate her commitment to improving patient care. Her work exemplifies the impact of scientific research on medical advancements.